Slimming hormone treatments: GH and IGF-1 (1h39)

Content is one video of 1h39, a PDF presentation file, and PDF references on:

Two major hormone therapies may considerably prevent overweight and reduce global or local fat accumulation on the body and improve body composition

• GH (growth hormone)
• IGF-1

Abstract:

This instructive video lecture offers new insights and solutions in weight loss management by correcting 4 major hormone deficiencies with hormone supplements.

The major hormone therapies that may considerably prevent or reduce local fat accumulation on the body while simultaneously improving body composition are growth hormone, and IGF-1. Growth hormone (GH) and insulin-like factor 1 (IGF-1) increase muscle mass and decrease fat mass.

Lower levels of growth hormone and IGF-1 are indisputably associated with higher risks of overweight and obesity. Trials with these hormones showing weight loss and improved body composition are discussed in depth in this presentation. This allows the physician to have a clear view of how much and how quick these hormone therapies can improve overweight patients. These fascinating slides show where exactly (and on which body parts) each of these hormone therapies preferably reduce fat, and the other slides address where there is myxedema accumulation. For each of these therapies, the best products and doses for overweight patients are presented and explained.

Attractive and informative pictures together with scientific data and practical tips make this video session a must to attend.

Educational outcome:
To transmit knowledge on how much growth hormone and IGF-1 deficiencies may facilitate or even cause overweight, and how hormone supplementations may restore a slim body.

Learning outcomes:

The physician learns

1. How to detect growth hormone and IGF-1 deficit(s) that cause or increase obesity on symptoms and signs related to overweight
2. How to differentiate clinically (symptomatically) which of these hormone deficiencies is behind the overweight by recognizing other signs or symptoms of the causative hormone deficiency
3. How to treat with growth hormone and IGF-1 and finetune the doses to the needs and degree of patients’ overweight
4. More about the scientific studies that support this information, including double-blind placebo-controlled trials